MedTrace Logo

COVID-19 and SARS-CoV-2 Detection in Saliva

NCT04517682 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 67

Last updated 2022-03-07

No results posted yet for this study

Summary

This study aims to validate the use of human saliva as a substrate for an assay to detect SARS-CoV-2 and define accuracy, analytical sensitivity and specificity of the TaqPath RT-PCR test.

Conditions

  • RNA Virus Infections

Interventions

DIAGNOSTIC_TEST

RT-PCR

The RT-PCR assay will be performed on paired nasopharyngeal and saliva samples

Sponsors & Collaborators

  • The Saratoga Hospital

    collaborator UNKNOWN

  • St. Joseph Hospital of Orange

    collaborator OTHER

  • Crozer-Keystone Health System

    collaborator OTHER

  • Ambry Genetics

    lead INDUSTRY

Principal Investigators

  • Brigette Tippin Davis, PhD · Ambry Genetics

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-21
Primary Completion
2021-03-16
Completion
2021-08-05

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04517682 on ClinicalTrials.gov